Objectives

Characterise the spectrum of cognitive and neurodegenerative complications resulting from COVID-19 in the chronic setting (Post-COVID)

Define the cellular and molecular mechanisms that ground the spectrum of NeuroCOVID disease trajectories

Develop AI-based predictive models to assess the risk of developing NeuroCOVID

Identify drug candidates and lay the foundation for NeuroCOVID personalised therapies

Map the key social challenges faced by Post-COVID patient populations